Conservative MPs use the short-term announcement of the export ban to call for an over-the-counter review of the industry agreement, as the EU leader attacks after a change of direction
Pfizer / BioNTech
United States / Germany
95% efficiency one week after the time of the trip. Pfizer says it is only 52% after the first dose, however the British Joint Committee on Immunization and Immunization (JCVI) says it can be 90% successful after 21 days.
The UK ordered millions of doses.
Dosage Clinical trials with two doses 21 days apart. The UK extends this era to 12 weeks.
Oxford v AstraZeneca
United Kingdom country
Efficacy 70. 4% 14 days after receiving the dose of the moment. It can be up to 90% effective when administered in partial doses followed by a full dose. There is no serious illness or hospitalization in others who won the vaccine. It was feared to be minor, effective against the South African variant of coronavirus.
The UK has ordered a hundred million doses.
Dosage Two, 4 to 12 weeks apart
Modern
U. S. country
The effects of the phase effectiveness test 3 94. 1%.
The UK ordered 17 million doses, to be delivered in March or April.
Dosage Two, 28 days apart
Novavax
U. S. country
Phase effectiveness tests 3 89. 3%.
60 million doses ordered across the UK, with distribution planned basically in the part of the year.
Dosage two
Janssen (part of Johnson
U. S. country
72% effectiveness in preventing mild to moderate cases in US trials is a 72% increase in the number of cases in the United States. But 66% efficacy observed in foreign trials. 85% effectiveness in the face of serious illness and 100 percent coverage of hospitalization and death
30 million doses ordered across the UK
Dosage: one, which makes it one of Covid’s vaccines with phase 3 effects to date
However, the dispute intensified Saturday after the prime minister and leader of Northern Ireland’s Democratic Unionist Party, Arlene Foster, called for the redesign of the entire agreement affecting the region, stating that the protocol was “impractical” and that serious disruptions had arisen. industry between Northern Ireland and Great Britain. It is understood that high-level conservatives will try to meet with Cabinet Minister Michael Gove to express their concerns. Teresa Villiers, former secretary of Northern Ireland, said: “It is important that the government seize this opportunity to speak harshly of the operation of the Northern Ireland Protocol with the EU.
“We have noticed that the EU is making a massive error of judgment. This is a vital time for us to point out some of the other serious flaws in the way it approaches Northern Ireland. That’s actually the message a lot of my colleagues have for Michael. Gove and also for the First Ministro. De fact, I need the protocol to be a compromise agreement, but now we can turn it into anything that can be achieved in large part».
David Jones, Brexiter and former conservative closet minister, said: “Protocol will have to disappear. The EU has demonstrated how it is in a position to militarise it, even without provocation, in a compatibility of spite. We want to put more”. practical measures in place. »
Gove said Saturday that he is seeking to “restore” relations with the EU over Northern Ireland. He also said that if the UK’s vaccine source is not affected, the government will seek to help other European countries, if it could. .
The commitment, despite everything agreed between the European Commission and Dublin, exempts vaccine brands from applying for authorisation for doses crossing the border with Northern Ireland, thus avoiding the concept of building a vaccine frontier in Ireland. take into account the number of doses distributed to Northern Ireland, a sign that the Commission remains involved in the fact that this may be only a secret direction for the movement of vaccines to the rest of the UK.
An EU official said: “We are also suspected that some vaccines are leaving Europe to come to us, so we have put this mechanism in a position to verify. “
Officials said Saturday that they remain committed to hold the brands accountable, as vaccine shortages across the bloc were reported. He is in dispute with AstraZeneca after the company says he could deliver only a fraction of the promised vaccines in the first place.
“We have a serious challenge with a company that signed a contract with us saying it had to supply us with vaccines from two UK plants, and it has not delivered a dose of those plants to singles,” an EU official said of AstraZeneca. He made it clear, with the support of the British government, that these plants will not deliver vaccines to the EU until the UK receives the hundred million doses it should receive. This is a serious challenge for us. “
AstraZeneca said he had a contractual legal responsibility to execute the UK order for one hundred million doses from the Oxford and Staffordshire factories before diverting the vaccine to the EU.